AAMU
SBBP

Amundi Asset Management US’s Strongbridge Biopharma plc. SBBP Stock Holding History

Amundi Asset Management US’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,400
Closed -$50K – 1692
2018
Q3 		$50K Hold
10,400
– – ﹤0.01% 1564
2018
Q2 		$62K Hold
10,400
– – ﹤0.01% 1500
2018
Q1 		$92K Buy
10,400
+3,300
+46% +$24.7K ﹤0.01% 1421
2017
Q4 		$51K Buy
+7,100
New +$44.4K ﹤0.01% 1491

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Amundi Asset Management US's SBBP Position: Q4 2018 in Review

Amundi Asset Management US sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2018, closing a stake of 10,400 shares — an estimated $50K sold.

Amundi Asset Management US first reported a position in SBBP in Q4 2017 and held it in 4 quarters. The position peaked at $92K in Q1 2018. 42 funds tracked by Wall St. Rank hold SBBP as of Q4 2018.

  • Amundi Asset Management US reported no remaining Strongbridge Biopharma plc. position as of Q4 2018 after selling out during the quarter.
  • Amundi Asset Management US sold 10,400 Strongbridge Biopharma plc. shares in Q4 2018, an estimated $50K.
  • Amundi Asset Management US first reported a position in Strongbridge Biopharma plc. in Q4 2017 and held it in 4 quarters.
  • Amundi Asset Management US's Strongbridge Biopharma plc. position peaked at $92K in Q1 2018.
  • 42 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2018.

Based on Amundi Asset Management US's 13F filing for Q4 2018, filed 14 Feb 2019.